Form4insider filings, from the source

SEC Form 4 · accession 0001493152-16-010950

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Dave Brian Miller
Officer — SVP Marketing
Period of report
Jun 17, 2016
Accepted (ET)
Jun 20, 2016 · 1:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 17, 2016P1,000$4.7243A4,600D
Common StockJun 17, 2016P500$4.7777A5,100D
Common StockJun 17, 2016P500$4.7903A5,600D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses